| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_69ece09bafee7e0c49d1f7951a3faa2c |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-3061
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6803
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-705
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6867
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705 |
| filingDate |
2009-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2012-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_383a65f4304c598761b817e9eecf816a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_809012cb820bf51b5cd5b5a5ea9217fc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f61bb807400f4c8fc771f384fb5f703
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f037104ac3a0f113e97cb5e64e6d372b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1261e795044af9e03a78c265d1ca89b3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d02fc5a5697a76ded7f209a44eebace3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e89cf88fa7360bf0e9087f05b05da294
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d2caac0364f99874806e1a2547fc4de
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e1904850377034b0d03f1e25333c30ee |
| publicationDate |
2012-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
AU-2009202783-B2 |
| titleOfInvention |
Compositions and methods for the treatment of tumor of hematopoietic origin |
| abstract |
COMPOSITIONS AND METHODS FOR THE TREATMENT OF TUMOR OF HEMATOPOIETIC ORIGIN Abstract of the Disclosure The present invention is directed to compositions of matter useful for the treatment of hematopoietic tumor in mammals and to methods of using those compositions of matter for the 10 same. N:\Perth\Cases\Patent\61 000-61999\P61247.AU. 1 \Specis\P61247.AU. 1 Specification 2009-7-7.doc 9/07/09 |
| priorityDate |
2003-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |